These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 34102717)

  • 1. [Progress of chronic mucus hypersecretion and chronic obstructive pulmonary disease].
    Tang X; Wan NS; Yang X; Cao J
    Zhonghua Jie He He Hu Xi Za Zhi; 2021 Jun; 44(6):574-578. PubMed ID: 34102717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrogen-rich saline inhibits tobacco smoke-induced chronic obstructive pulmonary disease by alleviating airway inflammation and mucus hypersecretion in rats.
    Liu Z; Geng W; Jiang C; Zhao S; Liu Y; Zhang Y; Qin S; Li C; Zhang X; Si Y
    Exp Biol Med (Maywood); 2017 Sep; 242(15):1534-1541. PubMed ID: 28795606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetics of Mucus Hypersecretion in Chronic Respiratory Diseases.
    Saco TV; Breitzig MT; Lockey RF; Kolliputi N
    Am J Respir Cell Mol Biol; 2018 Mar; 58(3):299-309. PubMed ID: 29096066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective-component compatibility of Bufei Yishen formula II inhibits mucus hypersecretion of chronic obstructive pulmonary disease rats by regulating EGFR/PI3K/mTOR signaling.
    Li J; Ma J; Tian Y; Zhao P; Liu X; Dong H; Zheng W; Feng S; Zhang L; Wu M; Zhu L; Liu S; Zhao D
    J Ethnopharmacol; 2020 Jul; 257():112796. PubMed ID: 32344236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Potential therapy for mucus hypersecretion in chronic obstructive pulmonary disease].
    Park JA; Adler KB
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(41):2890-2. PubMed ID: 17288783
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic mucus hypersecretion in COPD and death from pulmonary infection.
    Prescott E; Lange P; Vestbo J
    Eur Respir J; 1995 Aug; 8(8):1333-8. PubMed ID: 7489800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic Mucus Hypersecretion and the Natural History of Chronic Obstructive Pulmonary Disease.
    Lange P; Vestbo J
    Am J Respir Crit Care Med; 2016 Mar; 193(6):602-3. PubMed ID: 26977967
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of airway mucus hypersecretion in chronic airway inflammatory disease: Chinese expert consensus (English edition).
    Shen Y; Huang S; Kang J; Lin J; Lai K; Sun Y; Xiao W; Yang L; Yao W; Cai S; Huang K; Wen F
    Int J Chron Obstruct Pulmon Dis; 2018; 13():399-407. PubMed ID: 29430174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting airway mucus hypersecretion in chronic obstructive pulmonary disease.
    Tamaoki J
    Respir Investig; 2015 Nov; 53(6):247-8. PubMed ID: 26521101
    [No Abstract]   [Full Text] [Related]  

  • 10. MiR-31-5p: A shared regulator of chronic mucus hypersecretion in asthma and chronic obstructive pulmonary disease.
    Tasena H; Boudewijn IM; Faiz A; Timens W; Hylkema MN; Berg M; Ten Hacken NHT; Brandsma CA; Heijink IH; van den Berge M
    Allergy; 2020 Mar; 75(3):703-706. PubMed ID: 31545509
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group.
    Vestbo J; Prescott E; Lange P
    Am J Respir Crit Care Med; 1996 May; 153(5):1530-5. PubMed ID: 8630597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Would chronic mucus hypersecretion affect the clinical response to medications of COPD patients?
    Ko FWS; Hui DSC
    Respirology; 2022 Dec; 27(12):1006-1007. PubMed ID: 36031687
    [No Abstract]   [Full Text] [Related]  

  • 13. Epidemiological studies in mucus hypersecretion.
    Vestbo J
    Novartis Found Symp; 2002; 248():3-12; discussion 12-9, 277-82. PubMed ID: 12568485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes.
    Lange P; Nyboe J; Appleyard M; Jensen G; Schnohr P
    Thorax; 1990 Aug; 45(8):579-85. PubMed ID: 2402719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of simvastatin on airway inflammation and airway mucus hypersecretion in rats with chronic obstructive pulmonary disease].
    Wang S; Xiong L; Deng X; Ren W; Zhu C; Li C; Zhou Q
    Zhonghua Yi Xue Za Zhi; 2015 Jun; 95(22):1726-30. PubMed ID: 26704155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucus hypersecretion in chronic obstructive pulmonary disease.
    Rogers DF
    Novartis Found Symp; 2001; 234():65-77; discussion 77-83. PubMed ID: 11199104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unplugging Mucus in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.
    Mall MA
    Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S177-85. PubMed ID: 27115954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and future therapies for airway mucus hypersecretion.
    Barnes PJ
    Novartis Found Symp; 2002; 248():237-49; discussion 249-53, 277-82. PubMed ID: 12568498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucus hypersecretion in asthma is associated with rhinosinusitis, polyps and exacerbations.
    Martínez-Rivera C; Crespo A; Pinedo-Sierra C; García-Rivero JL; Pallarés-Sanmartín A; Marina-Malanda N; Pascual-Erquicia S; Padilla A; Mayoralas-Alises S; Plaza V; López-Viña A; Picado C
    Respir Med; 2018 Feb; 135():22-28. PubMed ID: 29414449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways.
    Lai H; Rogers DF
    J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):219-31. PubMed ID: 20695774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.